SC
CRVO icon

Steven Cohen’s CervoMed CRVO Stock Holding History

Steven Cohen’s Portfolio CRVO Stock Details CRVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-10,000
Closed -$233K – 1942
2024
Q1 		$233K Buy
+10,000
New +$133K ﹤0.01% 1860

Other funds holding CRVO

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CAM
Crown Advisors Management Larkspur, California $182M AUM 103.97% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Steven Cohen's CRVO Position: Q2 2024 in Review

Steven Cohen sold out of CervoMed (CRVO) in Q2 2024, closing a stake of 10,000 shares — an estimated $233K sold.

Steven Cohen first reported a position in CRVO in Q1 2024 and held it in 1 quarter. The position peaked at $233K in Q1 2024. 38 funds tracked by Wall St. Rank hold CRVO as of Q2 2024.

  • Steven Cohen reported no remaining CervoMed position as of Q2 2024 after selling out during the quarter.
  • Steven Cohen sold 10,000 CervoMed shares in Q2 2024, an estimated $233K.
  • Steven Cohen first reported a position in CervoMed in Q1 2024 and held it in 1 quarter.
  • Steven Cohen's CervoMed position peaked at $233K in Q1 2024.
  • 38 funds tracked by Wall St. Rank held CervoMed as of Q2 2024.

Based on Point72 Asset Management's 13F filing for Q2 2024, filed 14 Aug 2024.